|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 153.70 BDT | -0.77% |
|
+9.32% | +50.54% |
| 06-26 | Beximco suspension lifted; M1 payment date extension | AN |
| 06-24 | Beximco Pharmaceuticals PLC. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.77% | +9.32% | +23.45% | +28.40% | +50.54% | +66.16% | +5.13% | -16.06% | +102.48% | 561M | |
| -0.07% | -0.02% | +6.03% | +27.06% | +12.93% | +54.23% | +167.82% | +416.47% | +1,433.55% | 1,084B | |
| -1.91% | -1.62% | +9.19% | +7.24% | +25.04% | +65.58% | +62.23% | +52.44% | +110.50% | 634B | |
| -1.32% | -4.58% | +10.50% | +17.28% | +9.02% | +30.68% | +85.22% | +113.67% | +287.10% | 447B | |
| +0.18% | -1.76% | +5.24% | +5.94% | +2.22% | +29.04% | +26.48% | -4.98% | +31.11% | 330B | |
| -6.22% | -8.14% | -2.04% | -12.58% | -3.16% | +28.87% | +31.18% | +54.42% | +193.11% | 295B | |
| -1.27% | -2.91% | +5.00% | +1.74% | +13.41% | +27.42% | +44.91% | +46.34% | +52.89% | 285B | |
| -0.93% | -3.57% | +18.79% | +34.46% | -1.57% | -27.74% | -39.70% | +17.57% | +71.80% | 218B | |
| -1.19% | -2.98% | +5.35% | +2.08% | +10.90% | +22.42% | +61.53% | +48.04% | +126.62% | 199B | |
| -0.58% | +2.65% | +7.37% | -5.17% | +9.78% | +19.00% | +78.03% | +97.52% | +56.23% | 169B | |
| +0.73% | -0.39% | -5.74% | -11.00% | -2.71% | -5.22% | -32.10% | -38.84% | -32.99% | 137B | |
| -0.72% | -6.70% | +10.52% | +10.27% | +8.67% | +2.86% | +43.02% | +148.61% | +446.78% | 127B | |
| +0.62% | -0.60% | +2.30% | -2.84% | +7.12% | +21.23% | -7.52% | -13.97% | -23.36% | 118B | |
| -1.01% | -2.22% | +2.94% | -9.58% | +7.40% | +37.51% | +48.83% | +9.23% | -5.71% | 105B | |
| +1.47% | +1.63% | -0.73% | -5.49% | -7.54% | -8.21% | -18.91% | -12.31% | +2.25% | 103B | |
| +0.19% | +1.07% | -1.42% | -17.16% | -10.72% | +6.62% | +88.35% | +74.59% | +499.92% | 74.31B | |
| +2.14% | -4.99% | +42.86% | +25.34% | +36.99% | +85.51% | +2.35% | -0.26% | -45.33% | 55.6B | |
| +2.96% | +3.40% | +21.05% | -3.20% | -6.65% | +4.14% | +14.92% | -9.39% | +269.59% | 52.46B | |
| -0.97% | +4.82% | +6.89% | -6.75% | +11.64% | +22.88% | +22.40% | +47.89% | +26.92% | 52.94B | |
| -0.91% | -0.06% | +7.36% | -1.15% | -3.90% | -1.91% | +15.67% | - | - | 42.83B | |
| Average | -0.51% | +2.36% | +8.75% | +4.24% | +8.47% | +24.05% | +34.99% | +54.26% | +189.66% | 226.41B | |
| Weighted average by Cap. | -0.97% | +2.37% | +6.87% | +9.91% | +9.71% | +33.89% | +70.58% | +136.46% | +442.39% |
- Stock Market
- Stocks
- BXPHARMA Stock
- Sector Beximco Pharmaceuticals PLC.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
